Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

This IPO is entirely an offer for sale (OFS) of 5.96 crore equity shares by existing shareholders. The company itself will not receive any money from this offer. The price band has been set at Rs 570 ...

According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

The Rs 3,395 crore Initial Public Offering (IPO) of Anthem Biosciences, the Bangalore-based contract research, development, ...

Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...

Anthem Biosciences IPO got fully subscribed at 1.15 times on the second day of share sale on July 15. The initial share sale ...

Anthem Biosciences' IPO fully subscribed, investors optimistic about growth prospects amid global pharma shift from China to ...

Anthem Biosciences IPO sees 20% GMP premium and strong subscriptions on Day 2; check allotment, listing, and key dates now!

The mainline issue will close for public subscription on Wednesday, July 16. The basis of allotment of shares is likely to be ...

The initial public offering (IPO) of Anthem Biosciences was fully subscribed by the second day of bidding on Tuesday.The IPO ...

Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by ...

Anthem Biosciences, ₹3,395 crore IPO was fully subscribed by Day 2, with strong interest from non-institutional investors, ...